Natera Stock Price, News & Analysis (NASDAQ:NTRA)

$9.32 +0.26 (+2.87 %)
(As of 02/22/2018 04:00 PM ET)
Previous Close$9.32
Today's Range$9.09 - $9.73
52-Week Range$7.35 - $14.76
Volume206,000 shs
Average Volume121,166 shs
Market Capitalization$487.15 million
P/E Ratio-3.76
Dividend YieldN/A
Beta2.18

About Natera (NASDAQ:NTRA)

Natera logoNatera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).

Receive NTRA News and Ratings via Email

Sign-up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic & Testing Substances
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NTRA
CUSIPN/A
Phone650-249-9090

Debt

Debt-to-Equity Ratio2.43%
Current Ratio1.85%
Quick Ratio1.75%

Price-To-Earnings

Trailing P/E Ratio-3.76324994591859
Forward P/E Ratio-4.33
P/E GrowthN/A

Sales & Book Value

Annual Sales$217.07 million
Price / Sales2.31
Cash FlowN/A
Price / CashN/A
Book Value$2.03 per share
Price / Book4.59

Profitability

Trailing EPS($2.45)
Net Income$-95,760,000.00
Net Margins-62.34%
Return on Equity-197.09%
Return on Assets-68.72%

Miscellaneous

Employees852
Outstanding Shares53,770,000

Natera (NASDAQ:NTRA) Frequently Asked Questions

What is Natera's stock symbol?

Natera trades on the NASDAQ under the ticker symbol "NTRA."

How were Natera's earnings last quarter?

Natera Inc (NASDAQ:NTRA) announced its earnings results on Wednesday, November, 8th. The medical research company reported ($0.51) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.47) by $0.04. The medical research company had revenue of $56.66 million for the quarter, compared to analyst estimates of $55.31 million. Natera had a negative return on equity of 197.09% and a negative net margin of 62.34%. The business's revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.50) EPS. View Natera's Earnings History.

Where is Natera's stock going? Where will Natera's stock price be in 2018?

4 analysts have issued 12-month price objectives for Natera's stock. Their predictions range from $12.00 to $16.00. On average, they anticipate Natera's share price to reach $14.33 in the next twelve months. View Analyst Ratings for Natera.

What are Wall Street analysts saying about Natera stock?

Here are some recent quotes from research analysts about Natera stock:

  • 1. According to Zacks Investment Research, "Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. " (1/23/2018)
  • 2. Cowen Inc analysts commented, "Subsequent to the company's Q4 conference call (last week), we are reducing our estimates to reflect management commentary and 2017 guidance. While we believe the risk/reward is likely attractive at current levels, we are also reducing our price target to reflect our new revenue forecast and the heavy-H2 weighting of 2017 expectations...NTRA reported Q4 results last week and provided 2017 revenue guidance. In advance of the company's conference call (link to note), we had reduced our revenue estimates for Q4 and for 2017, by $1.5MM and $13MM, respectively, to reflect our estimated impact of the termination of the company's distribution agreement with BioReference Labs. Our reductions put us at the low end of the range of sell side estimates. Unfortunately, our estimates were not low enough for either period. Shares have traded off ~15% since the announcement and are off nearly 30% YTD." (3/14/2017)

Who are some of Natera's key competitors?

Who are Natera's key executives?

Natera's management team includes the folowing people:

  • Matthew Rabinowitz Ph.D., Chairman of the Board, President, Chief Executive Officer, Co-Founder (Age 44)
  • Jonathan Sheena, Co-Founder, Chief Technology Officer, Director (Age 44)
  • Michael Burkes Brophy, Chief Financial Officer (Age 37)
  • Roelof Frederick Botha, Lead Independent Director (Age 43)
  • Todd C. Cozzens, Independent Director (Age 61)
  • Edward C. Driscoll Jr. Ph.D., Independent Director (Age 64)
  • James I. Healy M.D. Ph.D., Independent Director (Age 52)
  • Gail Boxer Marcus, Independent Director (Age 60)

When did Natera IPO?

(NTRA) raised $101 million in an IPO on Thursday, July 2nd 2015. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. Morgan Stanle, Cowen and Company and Piper Jaffray acted as the underwriters for the IPO and Baird and Wedbush Pacgrow were co-managers.

Who owns Natera stock?

Natera's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Jennison Associates LLC (4.34%), Macquarie Group Ltd. (2.78%), Driehaus Capital Management LLC (1.93%), Franklin Resources Inc. (1.80%), Bank of New York Mellon Corp (0.99%) and Geode Capital Management LLC (0.66%). Company insiders that own Natera stock include Herm Rosenman, Jonathan Sheena, Matthew Rabinowitz and Roelof Botha. View Institutional Ownership Trends for Natera.

Who sold Natera stock? Who is selling Natera stock?

Natera's stock was sold by a variety of institutional investors in the last quarter, including Driehaus Capital Management LLC, Franklin Resources Inc., Advisory Research Inc., Millennium Management LLC, Bank of New York Mellon Corp, TIAA CREF Investment Management LLC, Jennison Associates LLC and Teachers Advisors LLC. Company insiders that have sold Natera company stock in the last year include Herm Rosenman and Jonathan Sheena. View Insider Buying and Selling for Natera.

Who bought Natera stock? Who is buying Natera stock?

Natera's stock was purchased by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., First Manhattan Co., Deutsche Bank AG, Wells Fargo & Company MN, Schwab Charles Investment Management Inc., Jefferies Group LLC, MetLife Investment Advisors LLC and Geode Capital Management LLC. View Insider Buying and Selling for Natera.

How do I buy Natera stock?

Shares of Natera can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natera's stock price today?

One share of Natera stock can currently be purchased for approximately $9.32.

How big of a company is Natera?

Natera has a market capitalization of $487.15 million and generates $217.07 million in revenue each year. The medical research company earns $-95,760,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis. Natera employs 852 workers across the globe.

How can I contact Natera?

Natera's mailing address is 201 INDUSTRIAL ROAD SUITE 410, SAN CARLOS CA, 94070. The medical research company can be reached via phone at 650-249-9090.


MarketBeat Community Rating for Natera (NTRA)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  144 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  263
MarketBeat's community ratings are surveys of what our community members think about Natera and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Natera (NASDAQ:NTRA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $14.33$14.33$15.00$15.75
Price Target Upside: 45.52% upside45.52% upside60.60% upside89.99% upside

Natera (NASDAQ:NTRA) Consensus Price Target History

Price Target History for Natera (NASDAQ:NTRA)

Natera (NASDAQ:NTRA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/21/2017CowenReiterated RatingBuy$12.00LowView Rating Details
11/14/2017Canaccord GenuityReiterated RatingBuy$15.00N/AView Rating Details
10/24/2017Robert W. BairdReiterated RatingBuyN/AView Rating Details
10/6/2017Morgan StanleyReiterated RatingOverweight$13.00 -> $16.00N/AView Rating Details
11/10/2016BenchmarkBoost Price TargetBuy$16.00 -> $20.00N/AView Rating Details
3/11/2016Piper Jaffray CompaniesReiterated RatingOverweight$24.00 -> $22.00N/AView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Natera (NASDAQ:NTRA) Earnings History and Estimates Chart

Earnings by Quarter for Natera (NASDAQ:NTRA)

Natera (NASDAQ NTRA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017Q3 2017($0.47)($0.51)$55.31 million$56.66 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.52)($0.52)$50.57 million$53.60 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.61)($0.70)$42.82 million$46.90 millionViewListenView Earnings Details
3/7/2017Q4 2016($0.54)($0.72)$49.82 million$49.30 millionViewListenView Earnings Details
11/9/2016Q316($0.55)($0.50)$48.14 million$53.89 millionViewListenView Earnings Details
8/4/2016Q216($0.48)($0.46)$50.64 million$52.00 millionViewListenView Earnings Details
5/10/2016Q116($0.46)($0.17)$48.17 million$61.90 millionViewListenView Earnings Details
3/8/2016Q415($0.64)($0.47)$45.26 million$52.90 millionViewListenView Earnings Details
11/12/2015Q315($0.46)($0.39)$43.08 million$44.90 millionViewListenView Earnings Details
8/12/2015Q2 2015($0.45)($2.98)$42.69 million$45.09 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Natera (NASDAQ:NTRA) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.15 EPS
Next Year EPS Consensus Estimate: $-1.32 EPS

Dividends

Dividend History for Natera (NASDAQ:NTRA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Natera (NASDAQ NTRA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 12.57%
Institutional Ownership Percentage: 66.01%
Insider Trades by Quarter for Natera (NASDAQ:NTRA)
Insider Trades by Quarter for Natera (NASDAQ:NTRA)

Natera (NASDAQ NTRA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/6/2017Jonathan SheenaInsiderSell120,000$12.54$1,504,800.00533,208View SEC Filing  
4/5/2017Herm RosenmanDirectorSell1,809$8.55$15,466.9542,950View SEC Filing  
1/4/2017Herm RosenmanCFOSell1,849$11.87$21,947.6333,409View SEC Filing  
12/22/2016Jonathan SheenaInsiderSell16,213$12.00$194,556.00645,972View SEC Filing  
12/20/2016Jonathan SheenaInsiderSell1,087$12.00$13,044.00630,846View SEC Filing  
12/13/2016Jonathan SheenaInsiderSell2,700$12.00$32,400.00632,459View SEC Filing  
12/6/2016Herm RosenmanCFOSell1,828$11.83$21,625.2430,237View SEC Filing  
12/5/2016Matthew RabinowitzCEOSell14,021$12.02$168,532.421,888,644View SEC Filing  
12/1/2016Matthew RabinowitzCEOSell56,072$12.01$673,424.721,942,572View SEC Filing  
11/28/2016Matthew RabinowitzCEOSell146,756$12.50$1,834,450.002,020,876View SEC Filing  
11/21/2016Jonathan SheenaInsiderSell32,505$12.00$390,060.00630,165View SEC Filing  
11/3/2016Herm RosenmanCFOSell1,852$7.98$14,778.96View SEC Filing  
10/6/2016Herm RosenmanCFOSell1,773$11.53$20,442.6922,051View SEC Filing  
10/5/2016Jonathan SheenaInsiderSell1,600$12.00$19,200.00617,151View SEC Filing  
9/6/2016Herm RosenmanCFOSell1,822$10.21$18,602.6218,873View SEC Filing  
8/2/2016Herm RosenmanCFOSell1,833$12.98$23,792.3415,706View SEC Filing  
7/6/2016Herm RosenmanCFOSell1,824$12.10$22,070.4012,530View SEC Filing  
7/1/2016Matthew RabinowitzCEOSell104,892$12.14$1,273,388.882,167,354View SEC Filing  
6/19/2016Jonathan SheenaCTOSell188,442$11.94$2,249,997.48598,420View SEC Filing  
6/19/2016Matthew RabinowitzCEOSell732,831$11.94$8,750,002.142,876,595View SEC Filing  
6/19/2016Roelof BothaDirectorBuy837,521$11.94$10,000,000.74View SEC Filing  
6/2/2016Herm RosenmanCFOSell1,806$12.04$21,744.249,336View SEC Filing  
2/1/2016Jonathan SheenaCTOSell10,000$8.03$80,300.00615,551View SEC Filing  
1/5/2016Matthew RabinowitzCEOSell54,683$10.37$567,062.712,762,777View SEC Filing  
1/4/2016Jonathan SheenaCTOSell25,000$10.06$251,500.00622,551View SEC Filing  
12/31/2015Matthew RabinowitzCEOSell111,513$10.83$1,207,685.792,817,460View SEC Filing  
12/29/2015Jonathan SheenaCTOSell50,000$10.44$522,000.00640,051View SEC Filing  
12/29/2015Matthew RabinowitzCEOSell83,804$10.62$889,998.482,928,973View SEC Filing  
7/8/2015James HealyDirectorBuy350,000$18.00$6,300,000.00View SEC Filing  
7/2/2015James HealyDirectorBuy400,000$22.81$9,124,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Natera (NASDAQ NTRA) News Headlines

Source:
DateHeadline
$56.83 Million in Sales Expected for Natera Inc (NTRA) This Quarter$56.83 Million in Sales Expected for Natera Inc (NTRA) This Quarter
www.americanbankingnews.com - February 20 at 1:04 PM
 Analysts Expect Natera Inc (NTRA) Will Announce Earnings of -$0.43 Per Share Analysts Expect Natera Inc (NTRA) Will Announce Earnings of -$0.43 Per Share
www.americanbankingnews.com - February 18 at 1:10 AM
Zacks: Brokerages Anticipate Natera Inc (NTRA) Will Post Quarterly Sales of $56.83 MillionZacks: Brokerages Anticipate Natera Inc (NTRA) Will Post Quarterly Sales of $56.83 Million
www.americanbankingnews.com - February 3 at 9:50 AM
-$0.43 EPS Expected for Natera Inc (NTRA) This Quarter-$0.43 EPS Expected for Natera Inc (NTRA) This Quarter
www.americanbankingnews.com - February 1 at 1:10 AM
Natera Inc (NTRA) Given Consensus Recommendation of "Hold" by BrokeragesNatera Inc (NTRA) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 30 at 1:52 PM
Natera To Feature Expanded Panorama® Non-Invasive Prenatal Test, Now Validated for Twin Pregnancies, at SMFM Annual MeetingNatera To Feature Expanded Panorama® Non-Invasive Prenatal Test, Now Validated for Twin Pregnancies, at SMFM Annual Meeting
finance.yahoo.com - January 30 at 9:26 AM
Natera (NTRA) Stock Rating Upgraded by BidaskClubNatera (NTRA) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - January 20 at 9:10 AM
 Analysts Expect Natera Inc (NTRA) to Post -$0.43 Earnings Per Share Analysts Expect Natera Inc (NTRA) to Post -$0.43 Earnings Per Share
www.americanbankingnews.com - January 15 at 3:30 AM
Natera (NTRA) Upgraded to "Hold" by Zacks Investment ResearchNatera (NTRA) Upgraded to "Hold" by Zacks Investment Research
www.americanbankingnews.com - January 10 at 6:44 AM
Natera To Webcast Live Presentation at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018Natera To Webcast Live Presentation at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018
finance.yahoo.com - January 8 at 9:43 AM
Natera Inc (NTRA) Expected to Post Quarterly Sales of $56.83 MillionNatera Inc (NTRA) Expected to Post Quarterly Sales of $56.83 Million
www.americanbankingnews.com - December 31 at 10:54 AM
ETFs with exposure to Natera, Inc. : December 25, 2017ETFs with exposure to Natera, Inc. : December 25, 2017
finance.yahoo.com - December 25 at 6:58 PM
Natera (NTRA) Earns "Buy" Rating from CowenNatera (NTRA) Earns "Buy" Rating from Cowen
www.americanbankingnews.com - December 21 at 11:22 AM
$56.53 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter$56.53 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter
www.americanbankingnews.com - December 14 at 6:28 PM
ETFs with exposure to Natera, Inc. : December 13, 2017ETFs with exposure to Natera, Inc. : December 13, 2017
finance.yahoo.com - December 13 at 5:22 PM
Natera, Inc. (NTRA) Receives Average Rating of "Hold" from AnalystsNatera, Inc. (NTRA) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 11 at 1:58 PM
ETFs with exposure to Natera, Inc. : December 1, 2017ETFs with exposure to Natera, Inc. : December 1, 2017
finance.yahoo.com - December 1 at 5:00 PM
Natera, Inc. :NTRA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017Natera, Inc. :NTRA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017
finance.yahoo.com - November 30 at 10:07 AM
Natera, Inc. (NTRA) Expected to Announce Quarterly Sales of $56.53 MillionNatera, Inc. (NTRA) Expected to Announce Quarterly Sales of $56.53 Million
www.americanbankingnews.com - November 26 at 12:12 PM
Zacks Investment Research Downgrades Natera, Inc. (NTRA) to SellZacks Investment Research Downgrades Natera, Inc. (NTRA) to Sell
www.americanbankingnews.com - November 25 at 8:10 PM
Head to Head Analysis: Natera (NTRA) & IRIS International (IRIS)Head to Head Analysis: Natera (NTRA) & IRIS International (IRIS)
www.americanbankingnews.com - November 17 at 1:42 PM
Natera, Inc. (NTRA) Receives Consensus Rating of "Hold" from BrokeragesNatera, Inc. (NTRA) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 16 at 11:54 AM
Nateras (NTRA) Buy Rating Reiterated at Canaccord GenuityNatera's (NTRA) Buy Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - November 14 at 8:28 PM
Natera, Inc. (NTRA) Announces Quarterly  Earnings ResultsNatera, Inc. (NTRA) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 9 at 10:52 PM
Natera, Inc. to Host Earnings CallNatera, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 9:38 AM
Natera Reports Third Quarter 2017 Financial ResultsNatera Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 9 at 9:38 AM
Natera reports 3Q lossNatera reports 3Q loss
finance.yahoo.com - November 9 at 9:38 AM
Edited Transcript of NTRA earnings conference call or presentation 8-Nov-17 9:30pm GMTEdited Transcript of NTRA earnings conference call or presentation 8-Nov-17 9:30pm GMT
finance.yahoo.com - November 9 at 9:38 AM
IRIS International (IRIS) and Natera (NTRA) Head to Head ReviewIRIS International (IRIS) and Natera (NTRA) Head to Head Review
www.americanbankingnews.com - November 7 at 11:00 AM
Natera Selected for Circulating Tumor DNA Study in Colorectal CancerNatera Selected for Circulating Tumor DNA Study in Colorectal Cancer
finance.yahoo.com - November 7 at 7:57 AM
ETFs with exposure to Natera, Inc. : November 6, 2017ETFs with exposure to Natera, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 7:57 AM
$55.24 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter$55.24 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter
www.americanbankingnews.com - November 7 at 5:52 AM
 Brokerages Anticipate Natera, Inc. (NTRA) Will Post Earnings of -$0.45 Per Share Brokerages Anticipate Natera, Inc. (NTRA) Will Post Earnings of -$0.45 Per Share
www.americanbankingnews.com - November 5 at 5:24 AM
Natera Inc. Announces Third Quarter 2017 Earnings Conference CallNatera Inc. Announces Third Quarter 2017 Earnings Conference Call
finance.yahoo.com - November 2 at 7:02 AM
Natera, Inc. (NTRA) to Release Quarterly Earnings on TuesdayNatera, Inc. (NTRA) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 31 at 8:52 AM
ETFs with exposure to Natera, Inc. : October 27, 2017ETFs with exposure to Natera, Inc. : October 27, 2017
finance.yahoo.com - October 28 at 9:57 AM
Natera, Inc. breached its 50 day moving average in a Bearish Manner : NTRA-US : October 25, 2017Natera, Inc. breached its 50 day moving average in a Bearish Manner : NTRA-US : October 25, 2017
finance.yahoo.com - October 25 at 8:25 AM
Nateras (NTRA) Buy Rating Reaffirmed at Robert W. BairdNatera's (NTRA) Buy Rating Reaffirmed at Robert W. Baird
www.americanbankingnews.com - October 24 at 4:26 PM
Natera, Inc. (NTRA) Given Average Rating of "Hold" by BrokeragesNatera, Inc. (NTRA) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - October 22 at 12:52 PM
ETFs with exposure to Natera, Inc. : October 17, 2017ETFs with exposure to Natera, Inc. : October 17, 2017
finance.yahoo.com - October 18 at 7:46 AM
Zacks: Brokerages Anticipate Natera, Inc. (NTRA) Will Post Quarterly Sales of $56.73 MillionZacks: Brokerages Anticipate Natera, Inc. (NTRA) Will Post Quarterly Sales of $56.73 Million
www.americanbankingnews.com - October 18 at 7:20 AM
-$0.46 Earnings Per Share Expected for Natera, Inc. (NTRA) This Quarter-$0.46 Earnings Per Share Expected for Natera, Inc. (NTRA) This Quarter
www.americanbankingnews.com - October 16 at 4:30 PM
Natera, Inc. (NTRA) Upgraded at Zacks Investment ResearchNatera, Inc. (NTRA) Upgraded at Zacks Investment Research
www.americanbankingnews.com - October 16 at 12:14 AM
Natera, Inc. (NTRA) Earns "Overweight" Rating from Morgan StanleyNatera, Inc. (NTRA) Earns "Overweight" Rating from Morgan Stanley
www.americanbankingnews.com - October 7 at 12:00 PM
ETFs with exposure to Natera, Inc. : October 6, 2017ETFs with exposure to Natera, Inc. : October 6, 2017
finance.yahoo.com - October 7 at 6:43 AM
Natera, Inc. :NTRA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017Natera, Inc. :NTRA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017
finance.yahoo.com - October 5 at 12:33 PM
Nateras Panorama Non-Invasive Prenatal Test Now Available for Screening Twin PregnanciesNatera's Panorama Non-Invasive Prenatal Test Now Available for Screening Twin Pregnancies
finance.yahoo.com - October 2 at 6:41 PM
$55.93 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter$55.93 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter
www.americanbankingnews.com - September 29 at 4:46 AM
-$0.46 EPS Expected for Natera, Inc. (NTRA) This Quarter-$0.46 EPS Expected for Natera, Inc. (NTRA) This Quarter
www.americanbankingnews.com - September 28 at 12:34 AM
Natera, Inc. (NTRA) Given Average Recommendation of "Hold" by BrokeragesNatera, Inc. (NTRA) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - September 27 at 2:50 PM

SEC Filings

Natera (NASDAQ:NTRA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Natera (NASDAQ:NTRA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Natera (NASDAQ NTRA) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.